Technetium 99m sestamibi in the assessment of myocardial salvage

Research output: Contribution to journalArticle

Abstract

Myocardium at risk in patients with acute myocardial infarction can be assessed by use of the perfusion agent technetium Tc99m sestamibi. Studies with this agent have demonstrated significant myocardial salvage in patients treated with thrombolysis. Sequential imaging with technetium 99m sestamibi appears to offer advantages over other methods of assessing treatment benefit.

Original languageEnglish (US)
Pages (from-to)47-48+50+53
JournalPrimary Cardiology
Volume18
Issue number10
StatePublished - 1992

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this